Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 13/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6236125 | 1.00 | PRKCA (0.44) | PRKCACNR2SIRT2ALDH1A1TSHR | |
| SCHEMBL11220241 | 0.76 | PRKCA (0.43) | PRKCASIRT2ALDH1A1TSHRFAAH | |
| SCHEMBL21703311 | 0.73 | PTPN1 (0.33) | PRKCA | |
| SCHEMBL27871758 | 0.71 | TSHR (0.32) | PRKCAALDH1A1TSHRFAAH | |
| SCHEMBL11356769 | 0.70 | PRKCA (0.36) | PRKCACNR2SIRT2ALDH1A1TSHR | |
| SCHEMBL21679743 | 0.69 | — | — | |
| SCHEMBL21679741 | 0.69 | — | — | |
| SCHEMBL4867837 | 0.69 | MGLL (0.40) | PRKCACNR2FAAHMGLL | |
| SCHEMBL8516656 | 0.69 | PRKCA (0.48) | PRKCASIRT2 | |
| SCHEMBL7530064 | 0.68 | LMNA (0.33) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6939845-B2 | Fragrance precursors | GIVAUDAN SA (CH) | 2005-09-06 | — | — | US | disclosed |
| EP-1167362-B1 | Fragance precursors | GIVAUDAN SA (CH) | 2005-05-25 | — | — | EP | disclosed |
| US-20020035055-A1 | Fragrance precursors | GIVAUDAN SA (CH) | 2002-03-21 | — | — | US | disclosed |
| EP-1167362-A1 | Fragance precursors | Givaudan SA (CH) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035055-A1 | Fragrance precursors | FAAH2, FDPS, CYP51A1 | PRKCA 3621/4885CNR2 622/4885SIRT2 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.